Related Experiment Video

Updated: Jun 7, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

The relationship between HBV-DNA level and histology in patients with naive chronic HBV infection

Rukiye Vardar1, Fulya Gunsar, Ruchan Sertoz

  • 1Ege University School of Medicine, Department of Gastroenterology, Izmir, Turkey. rukiye.vardar@ege.edu.tr

Hepato-Gastroenterology
|November 2, 2010
PubMed

Insights

A serum hepatitis B virus DNA (HBV-DNA) level of 15,000 copies/mL can help identify patients with chronic hepatitis B (CHB) who have low disease activity. These patients may not require liver biopsy, simplifying their management.

Area of Science:

  • Hepatology
  • Virology
  • Gastroenterology

Background:

  • Accurate staging of hepatic fibrosis is crucial for managing chronic hepatitis B (CHB).
  • Hepatitis B virus DNA (HBV-DNA) levels are increasingly recognized as important prognostic markers in CHB.
  • Understanding the correlation between HBV-DNA and liver histology aids in risk stratification.

Purpose of the Study:

  • To investigate the relationship between serum HBV-DNA levels and liver histology in CHB patients.
  • To determine a threshold HBV-DNA level for differentiating low-risk from high-risk patients for disease progression.

Main Methods:

  • Evaluation of 259 treatment-naïve CHB patients with HBV-DNA > 2000 copies/mL.
  • Liver biopsies assessed histopathologically using the Ishak scoring system.
  • Regular monitoring of liver enzymes (AST, ALT) and highest values recorded.

Main Results:

  • The study included 259 patients (60% male, mean age 40).
  • Mean HBV-DNA level was 5.9 log copies/mL; mean fibrosis score was 1.38.
  • An HBV-DNA threshold of 15,000 copies/mL was identified, below which patients typically showed low fibrosis and inflammation (fibrosis score < 2, grade ≤ 5).

Conclusions:

  • Serum HBV-DNA levels ≤ 15,000 copies/mL are associated with low histological activity in CHB patients.
  • These patients may not require liver biopsy, irrespective of their hepatitis B e-antigen (HBeAg) status.
  • This finding can help streamline CHB patient management and reduce the need for invasive procedures.
Abstract

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...